‘A World with Drugs: Legal Regulation through a Development Lens.’

Invitation to webinar series running September~December

We are delighted to be sharing news of an 8-part international webinar series, co-organised by our friends and colleagues at Health Poverty Action. It will explore why drug policy reform is vital for sustainable development.
Drug policy has been undermining progress towards development for decades – it has fuelled violence and conflict, undermined democracy, driven poverty, inequality and poor health, and prevented access to vital medicines worldwide. Furthermore, drug policy reform – especially legal regulation – could significantly contribute to achieving sustainable development if done in the right way

The decades-long ‘War on Drugs’ and its impact on international development has been an issue TPNS has worked on previously, convinced that the evidence points in one direction only: for all the political capital and money thrown at it, it has been an abject failure on just about every count.

This new international webinar series explores the intersection of drug policy reform and development related issues such as trade justice, tax justice, climate justice, sustainable livelihoods and community participation.  Between September and December, the webinar series will look at how drug policy reform is vital if we wish to achieve sustainable development worldwide.

So much of society – local, regional, national and global – is affected by this issue. To dive deep and learn more about an issue in much greater need of public awareness, do sign up for one or more of the series.

Register for all the webinars here.

First Webinar Speakers:
Helen Clark – Former Prime Minister of New Zealand and Chair of the Global Commission on Drug Policy;
Philasande Mahlakata – Project Coordinator for Umzimvubu Farmers Support Network, South Africa;
Duncan Green – Senior Strategic Adviser at Oxfam GB and Professor in Practice in International Development at the London School of Economic;
Ann Fordham – Executive Director for International Drug Policy Consortium.